BidaskClub upgraded shares of Phibro Animal Health (NASDAQ:PAHC) from a strong sell rating to a sell rating in a research note released on Saturday.
A number of other equities research analysts have also issued reports on PAHC. Zacks Investment Research lowered Phibro Animal Health from a buy rating to a hold rating in a research note on Wednesday, November 1st. ValuEngine downgraded Phibro Animal Health from a buy rating to a hold rating in a report on Thursday, November 9th. Finally, Piper Jaffray Companies restated a buy rating and set a $42.00 price objective on shares of Phibro Animal Health in a report on Friday, November 10th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the stock. The company presently has an average rating of Hold and an average price target of $38.25.
Shares of Phibro Animal Health (NASDAQ:PAHC) opened at $35.40 on Friday. Phibro Animal Health has a one year low of $26.10 and a one year high of $40.25. The company has a current ratio of 3.26, a quick ratio of 1.85 and a debt-to-equity ratio of 1.91. The stock has a market capitalization of $1,410.00, a P/E ratio of 20.82, a P/E/G ratio of 4.12 and a beta of 1.27.
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, December 27th. Shareholders of record on Wednesday, December 6th were issued a dividend of $0.10 per share. The ex-dividend date of this dividend was Tuesday, December 5th. This represents a $0.40 annualized dividend and a yield of 1.13%. Phibro Animal Health’s payout ratio is currently 23.53%.
Several large investors have recently made changes to their positions in the company. Vanguard Group Inc. increased its holdings in shares of Phibro Animal Health by 3.0% in the 2nd quarter. Vanguard Group Inc. now owns 1,780,880 shares of the company’s stock valued at $65,982,000 after acquiring an additional 51,474 shares during the period. Copper Rock Capital Partners LLC increased its holdings in shares of Phibro Animal Health by 9.6% in the 4th quarter. Copper Rock Capital Partners LLC now owns 631,876 shares of the company’s stock valued at $21,326,000 after acquiring an additional 55,235 shares during the period. FMR LLC increased its holdings in shares of Phibro Animal Health by 31.9% in the 2nd quarter. FMR LLC now owns 584,463 shares of the company’s stock valued at $21,654,000 after acquiring an additional 141,274 shares during the period. Dimensional Fund Advisors LP increased its holdings in shares of Phibro Animal Health by 11.8% in the 3rd quarter. Dimensional Fund Advisors LP now owns 465,297 shares of the company’s stock valued at $17,239,000 after acquiring an additional 49,296 shares during the period. Finally, Ameriprise Financial Inc. increased its holdings in shares of Phibro Animal Health by 26.7% in the 3rd quarter. Ameriprise Financial Inc. now owns 430,656 shares of the company’s stock valued at $15,958,000 after acquiring an additional 90,660 shares during the period. Institutional investors and hedge funds own 48.42% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: This piece was originally published by Community Financial News and is owned by of Community Financial News. If you are viewing this piece on another website, it was stolen and republished in violation of United States and international trademark and copyright law. The legal version of this piece can be accessed at https://www.com-unik.info/2018/01/10/phibro-animal-health-pahc-lifted-to-sell-at-bidaskclub.html.
Phibro Animal Health Company Profile
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.